LPAR1 and hepatocellular carcinoma: LPAR1 overexpression has been shown to promote fibrosis [142], inflammation and HCC carcinogenesis via upregulation of its downstream effectors, including RhoA/ROCK, RAS/MAPK/ERK, and AKT/PI3K (Figure 3) [143].